Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease
ABSTRACT The mycobacterial caseinolytic protease ClpP1P2 is a degradative protease that recently gained interest as a genetically and pharmacologically validated drug target for tuberculosis. The first whole-cell active ClpP1P2 inhibitor, the human proteasome inhibitor bortezomib, is currently under...
Guardado en:
Autores principales: | Yoshiyuki Yamada, Thomas Dick |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd664c524a7b41c0ab4868df940839d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Technical data on the inhibition properties of some medicinal plant extracts towards caseinolytic protease proteolytic subunit of Plasmodium knowlesi
por: Raimalynah Abd Razak, et al.
Publicado: (2021) -
Synthetic Gene-Based Heterologous Expression, Proteolytic, and Structural Characterization of Caseinolytic Protease of Lactobacillus plantarum IIA-1A5
por: M. Yusuf, et al.
Publicado: (2021) -
Target Mechanism-Based Whole-Cell Screening Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria
por: Wilfried Moreira, et al.
Publicado: (2015) -
Type VII Secretion Substrates of Pathogenic Mycobacteria Are Processed by a Surface Protease
por: Maroeska J. Burggraaf, et al.
Publicado: (2019) -
Protease Inhibitor and Metabolic Alteration
por: Cavenaghi,F. M, et al.
Publicado: (2012)